MONKEYPOX (MPOX)
Clinical trials for MONKEYPOX (MPOX) explained in plain language.
Never miss a new study
Get alerted when new MONKEYPOX (MPOX) trials appear
Sign up with your email to follow new studies for MONKEYPOX (MPOX), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Mpox vaccine gets a production upgrade: new cell recipe under trial
⭐️ VACCINE ⭐️ OngoingThis study tests whether the MVA-BN mpox vaccine (Jynneos) works as well when made in quail cells instead of chicken cells. About 970 healthy adults aged 18 to 49 will receive two doses four weeks apart. Researchers will compare immune responses and side effects between the two v…
Matched conditions: MONKEYPOX (MPOX)
Phase: PHASE2 • Sponsor: Bavarian Nordic • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:05 UTC
-
Mpox vaccine trial expands to children: a step toward broader protection
⭐️ VACCINE ⭐️ OngoingThis study tests the MVA-BN vaccine in 460 children aged 2 to 12 years, comparing their immune response and safety to adults. All participants receive two doses four weeks apart. The goal is to see if the vaccine can prevent smallpox, mpox, and related orthopoxvirus infections in…
Matched conditions: MONKEYPOX (MPOX)
Phase: PHASE2 • Sponsor: Bavarian Nordic • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 07:59 UTC